GSK vs TSN · P/E 13, $103.31B cap vs P/E 22, rev $54.44B
GlaxoSmithKline PLC ADR (GSK) versus Tyson Foods Inc (TSN) — a side-by-side from cached financials, not a winner call.
GlaxoSmithKline PLC ADR (GSK) is a drug manufacturers - general company listed on US.
Tyson Foods Inc (TSN) is a farm products company listed on US.
GSK does not have a complete income-statement cache yet.
Latest reported TSN revenue for 2025-09-27 was $54.44B. Net income was $507.0M. TSN currently screens at market cap $20.43B and trailing P/E 22.3.
GSK currently screens at market cap $103.31B and trailing P/E 13.5. TSN currently screens at market cap $20.43B and trailing P/E 22.3.
Not investment advice. Open the GSK and TSN stock pages for the full models.
Not investment advice.